Skip to content

Clinical trials

Completed Lymphoma, B-Cell trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, B-Cell Status: Completed Country / region: Germany Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20063
20092
20101
20121
20134
20142
20163
20171
20182
20194
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
Pfizer3
Millennium Pharmaceuticals, Inc.2
Miltenyi Biomedicine GmbH2
Regeneron Pharmaceuticals2
AstraZeneca1
Bristol-Myers Squibb1
Celgene1
Epizyme, Inc.1
GWT-TUD GmbH1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, B-Cell25
Lymphoma, Large B-Cell, Diffuse9
Lymphoma7
Lymphoma, Non-Hodgkin7
Recurrence6
Lymphoma, Follicular4
Lymphoma, T-Cell3
Multiple Myeloma3
Hodgkin Disease2
Immune System Diseases2

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.